Inflammatory bowel diseases: where we are and where we should go

被引：6
作者：
Tonutti, Elio [2 ]
Agostinis, Paolo [3 ]
Bizzaro, Nicola [1 ]
机构：
[1] Osped San Antonio, Lab Patol Clin, I-33028 Tolmezzo, Italy
[2] Azienda Osped Univ S Maria della Misericordia, Immunopatol & Allergol Clin, Udine, Italy
[3] Osped San Antonio, Unita Med Interna, Serv Gastroenterol, I-33028 Tolmezzo, Italy
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2014年 / 52卷 / 04期
关键词：
ANTIBODIES;
D O I：
10.1515/cclm-2014-0146
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：463 / 465
页数：3
相关论文
共 50 条
  • [41] Vaccine therapies for chronic hepatitis B: can we go further?
    Wen, Yumei
    Wang, Xuanyi
    Wang, Bin
    Yuan, Zhenhong
    FRONTIERS OF MEDICINE, 2014, 8 (01) : 17 - 23
  • [42] Inflammatory bowel diseases and Takayasu's arteritis: coincidence or association?
    Kilic, Levent
    Kalyoncu, Umut
    Karadag, Omer
    Akdogan, Ali
    Dogan, Ismail
    Bilgen, Sule Apras
    Kiraz, Sedat
    Ertenli, Ihsan
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (08) : 814 - 818
  • [43] Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
    Roblin, Xavier
    Rinaudo, M.
    Del Tedesco, E.
    Phelip, J. M.
    Genin, C.
    Peyrin-Biroulet, L.
    Paul, S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (08) : 1250 - 1256
  • [44] From bench to bedside: molecular imaging in inflammatory bowel diseases
    Atreya, Raja
    Neurath, Markus F.
    CURRENT OPINION IN GASTROENTEROLOGY, 2016, 32 (04) : 245 - 250
  • [45] Interstitial lung pathology: Should we test for autoantibodies to cellular antigens?
    Serelis, J.
    Athanasakos, A.
    Skopouli, F. N.
    Moutsopoulos, H. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (02) : 340 - 341
  • [46] How should we treat palindromic rheumatism? A systematic literature review
    Corradini, Davide
    Matteo, Andrea Di
    Emery, Paul
    Mankia, Kulveer
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (01) : 266 - 277
  • [47] The Middle East Respiratory Syndrome-How Worried Should We Be?
    Perlman, Stanley
    MBIO, 2013, 4 (04):
  • [48] TROUGH LEVELS OF TNF-A INHIBITORS AND THEIR IMMUNOGENICITY IN THE TREATMENT OF RHEUMATIC DISEASES AND INFLAMMATORY BOWEL DISEASES
    Nuriakhmetova, T.
    Valeeva, I. K.
    Shevnina, J.
    Abdulganieva, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1269 - 1270
  • [49] GenotypeSerotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases
    Ben-Shachar, Shay
    Finezilber, Yael
    Elad, Hofit
    Rabinowitz, Keren
    Goren, Idan
    Isakov, Ofer
    Yanai, Henit
    Dotan, Iris
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (02) : 336 - 344
  • [50] The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases
    Kantasiripitak, Wannee
    Verstockt, Bram
    Alsoud, Dahham
    Lobaton, Triana
    Thomas, Debby
    Gils, Ann
    Vermeire, Severine
    Ferrante, Marc
    Dreesen, Erwin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (10) : 3776 - 3789
12345